Overcoming technical challenges in the development of cancer vaccines.

Abstract

Cancer vaccines have been developed using a wide range of technologies, yielding agents ranging from nonspecific immunostimulants through to highly technical peptide- and DNA-based candidates. There are many technical challenges involved in even the most basic decisions in vaccine development, such as the choice of antigen, formulation, adjuvant, route of… (More)

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics